Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


HEALTHCARE RLTY   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2021202020192018201720162015201420132012
Period End Date12/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/2012
Rental income763.92738.41691.53696.03612.56460.56403.55369.57319.04295.34
Interest income from mortgage notes receivable and other income3.150.550.510.401.430.370.271.932.564.30
Total Revenues767.07738.97692.04696.43613.99460.93403.82371.51321.60299.64
Rental236.85226.86211.48220.62192.15143.75123.39113.5197.3295.31
Depreciation and amortization303.83303.83290.38279.63244.99176.87154.13140.43121.65116.42
General and administrative49.7442.9741.3635.2033.4028.7725.5824.9524.4521.74
Acquisition-related------------4.569.557.528.84
Impairment(22.94)----(8.89)(13.92)(3.08)(2.58)------
Listing----------------(4.41)(22.57)
Non-traded REIT------------------(4.34)
Redemption, termination, and release payment to former advisor--------------------
Transaction(0.37)(0.97)(2.35)(1.00)(5.89)(6.54)--------
TOTAL OPERATING EXPENSE----------359.01310.24288.43255.34269.22
Operating income------------93.5883.0766.2630.42
Interest related to debt92.7694.6196.63101.8585.4959.7754.9751.5947.1040.38
Interest related to derivative financial instruments and net change in fair value of derivative financial instruments------------3.145.905.314.94
Interest expense-Net gain (loss) on change in the fair value of derivative financial instruments----------(1.34)0.772.87(10.80)7.67
Interest related to derivative financial instruments----------2.38------4.94
Gain on sales of real estate39.239.59(0.15)165.9837.808.970.1527.89----
Loss on sale of corporate asset, net(2.11)------------------
Other income0.490.300.840.430.030.29(1.43)0.050.040.09
Debt extinguishment costs--(27.73)(21.65)0.24(11.19)(3.03)0.12(4.66)--(1.89)
Income from unconsolidated joint venture1.601.611.881.740.78--0.00------
Income (loss) from continuing operations--------------------
Income from discontinued operations--------------------
Consolidated net income (loss)99.7853.5130.76217.6365.5847.3533.5645.9924.68(24.37)
Less: net (income) loss attributable to noncontrolling interests1.770.890.604.161.661.430.630.620.420.06
Net income (loss) available to common shareholders98.0252.6230.15213.4663.9245.9132.9345.3724.26(24.42)
EPS (Basic) : Income from continuing operations--------------------
EPS (Basic) : Income from discontinued operations--------------------
Net Earnings Per Share (Basic)0.450.240.151.040.350.340.260.380.21(0.22)
EPS (Diluted) : Income from continuing operations--------------------
EPS (Diluted) : Income from discontinued operations--------------------
Net Earnings Per Share (Diluted)0.440.240.141.020.340.330.260.370.21(0.22)
Weighted Average Shares Outstanding (Basic)219.44218.08205.72206.07181.06136.62126.07119.90114.04111.36
Weighted Average Shares Outstanding (Diluted)224.22221.67209.61210.06185.28140.26128.00121.17114.97111.36
Funds From operations386.39344.70319.74335.57284.23215.57188.21157.75145.9191.99